What Is Ibogaine? How Psychedelic Could Help Treat Veterans' Depression
Summary
President Donald Trump signed an executive order directing federal agencies to speed up research on certain psychedelic drugs, including ibogaine, to help treat veterans with mental health issues like depression and PTSD. The order aims to make it faster to review these drugs and support clinical trials, although the drugs remain illegal under federal law.Key Facts
- President Trump signed the order to accelerate research on psychedelics on a Saturday ceremony in the Oval Office.
- The order includes ibogaine, psilocybin, MDMA, and LSD, which are still Schedule I controlled substances federally.
- Veterans face higher rates of PTSD, depression, and suicide risk compared to civilians.
- The FDA will offer priority review vouchers to speed approval if treatments meet national priorities.
- Ibogaine is a substance from an African shrub and has been used in traditional ceremonies.
- Some veterans report improvement in mental health after taking ibogaine abroad.
- Safety concerns about ibogaine include heart issues and recorded deaths.
- Texas has approved $50 million to fund ibogaine clinical trials, supported by veterans and political leaders.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
